Stay updated on Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedNIH funding information was added to the study details, clarifying the source of support. The page revision was updated to v3.6.6, reflecting a new version of the page.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision: v3.6.5 replaces v3.6.4, reflecting a small site update. The change does not modify the study content or data shown on the page.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page's revision label updated from v3.6.3 to v3.6.4, signaling a new version of the document. This change does not modify any study data or visible content.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, representing a minor version update to the page's metadata.SummaryDifference0.1%

- Check71 days agoChange DetectedA new 2026 publication citation was added to the Publications section. The previous 2025 online-ahead-of-print citation was replaced with updated bibliographic details.SummaryDifference0.1%

- Check86 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating the study is no longer enrolling. Additional changes include adding user-help sections (How to Read a Study Record, Common Questions, How to Join a Study), standardizing the Intervention header to 'Intervention/Treatment', and updating the page revision to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial page.